NorthWest Biotherapeutics Inc (NWBO)

[jimmy667]

There is no 90 day stock minimum value requirement. Case in point Anavex Life Sciences "October Surprize" where management did an Up List overnight by a 4 for 1 reverse split then uplisted overnight to Nasdaq all by surprise. The next day it was trading under the ticker AVXLD for a number of days and quickly rose from $4.10 to $14.73 before retracing. AVXL was an extremely volatile issue and heavily shorted. Those that held for 5 years were rewarded by plus 350% to today. Trough of $1.26 to peak of $30 plus inside of18 months or 25x. Arrowhead Research had the same type of 18 month 25x run from an almost exactly low market cap as AVXL eighteen months prior to the AVXL run. ARWR had a 12 year extreme price suppression as both AVXL and NWBO. One can look at the 20 year chart of ARWR AVXL and NWBO on Barchart.com for a graphic display of this. One can see the chart of market cap appreciation of each of these on a twenty year market cap chart on Ycharts.com.
Clearly patience pays if too early as long a the business prospects of disruptive biotech is sound. Not good to be too early but better than to be too late.
NWBO was on my watch list for 5 years before I invested as I was slowly accumulating AVXL over those 5 years, pouncing on the bear raids.
ARWR was invested at $12- 17.
NWBO is under heavy accumulation at this time. If and when NWBO up lists the price might explode 25x in 18 months. NWBO could up list as early as Monday November 21, 2022 but maybe more likely shortly after the ASM. NWBO will not likely languish on OTC or this ridiculously low valuation for long. What I find in common amongst these exploding biotechs is not a watershed event, although NWBO is in a watershed event now, is an almost out of the blue "Market Recognition" of the true value on no news. A rush of investment into the stock resulting in a "Blue Sky Tornado". These often happen in other biotechs as well I just give a couple of examples.
Go Go NWBO.